Topics

How to increase the number of European-based ATMP clinical trials?

07:40 EDT 2 Nov 2019 | BioPharmaAnalyses

How to increase the number of European-based ATMP clinical trials? The latest report published by the Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapy and broader advanced therapies sector, shows that Europe has become less competitive than other regions in attracting new advanced therapy medicinal products(ATMPs) clinical trials. […]

Original Article: How to increase the number of European-based ATMP clinical trials?

NEXT ARTICLE

More From BioPortfolio on "How to increase the number of European-based ATMP clinical trials?"

Quick Search

Relevant Topics

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...